Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 747020, 9 pages
http://dx.doi.org/10.1155/2012/747020
Review Article

Vitamin E as an Antiosteoporotic Agent via Receptor Activator of Nuclear Factor Kappa-B Ligand Signaling Disruption: Current Evidence and Other Potential Research Areas

Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia

Received 10 May 2012; Accepted 26 June 2012

Academic Editor: Ahmad Nazrun Shuid

Copyright © 2012 Kok-Yong Chin and Soelaiman Ima-Nirwana. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. Doran and S. Khosla, “Osteoporosis,” in Contemporary Endocrinology: Handbook of Diagnostic Endocrinology, J. E. Hall and L. K. Nieman, Eds., pp. 257–275, Humana Press, Totowa, NJ, USA, 2003. View at Google Scholar
  2. O. Johnell and J. A. Kanis, “An estimate of the worldwide prevalence and disability associated with osteoporotic fractures,” Osteoporosis International, vol. 17, no. 12, pp. 1726–1733, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. C. D. Mathers and D. Loncar, “Projections of global mortality and burden of disease from 2002 to 2030,” PLoS Medicine, vol. 3, no. 11, pp. 2011–2030, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Handa, A. Ali Kalla, and G. Maalouf, “Osteoporosis in developing countries,” Best Practice and Research, vol. 22, no. 4, pp. 693–708, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. B. L. Riggs, S. Khosla, and L. J. Melton, “Sex steroids and the construction and conservation of the adult skeleton,” Endocrine Reviews, vol. 23, no. 3, pp. 279–302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. K.-Y. Chin, S. Ima-Nirwana, M. Isa Naina et al., “Calcaneal quantitative ultrasound value for middle-aged and elderly Malaysian Chinese men and its association with age and body anthropometry,” Journal of Clinical Densitometry, vol. 15, no. 1, pp. 86–91, 2012. View at Publisher · View at Google Scholar
  7. S. Khosla, B. L. Riggs, E. J. Atkinson et al., “Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment,” Journal of Bone and Mineral Research, vol. 21, no. 1, pp. 124–131, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Burge, B. Dawson-Hughes, D. H. Solomon, J. B. Wong, A. King, and A. Tosteson, “Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025,” Journal of Bone and Mineral Research, vol. 22, no. 3, pp. 465–475, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. O. Ström, F. Borgström, J. Kanis et al., “Osteoporosis: burden, health care provision and opportunities in the EU,” Archives of Osteoporosis, vol. 6, no. 1, pp. 59–155, 2011. View at Google Scholar
  10. E. F. Eriksen, S. F. Hodgson, R. Eastell, S. L. Cedel, W. M. O'Fallon, and B. L. Riggs, “Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels,” Journal of Bone and Mineral Research, vol. 5, no. 4, pp. 311–319, 1990. View at Google Scholar · View at Scopus
  11. J. Caetano-Lopes, H. Canhão, and J. E. Fonseca, “Osteoblasts and bone formation,” Acta reumatológica portuguesa, vol. 32, no. 2, pp. 103–110, 2007. View at Google Scholar · View at Scopus
  12. F. Arai, T. Miyamoto, O. Ohneda et al., “Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors,” Journal of Experimental Medicine, vol. 190, no. 12, pp. 1741–1754, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Sobacchi, A. Frattini, M. M. Guerrini et al., “Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL,” Nature Genetics, vol. 39, no. 8, pp. 960–962, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Yamashita, Z. Yao, F. Li et al., “NF-κB p50 and p52 regulate receptor activator of NF-κB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1,” Journal of Biological Chemistry, vol. 282, no. 25, pp. 18245–18253, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Takayanagi, S. Kim, T. Koga et al., “Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts,” Developmental Cell, vol. 3, no. 6, pp. 889–901, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. National Osteoporosis Foundation, Physician's Guide To Prevention and Treatment of Osteoporosis, National Osteoporosis Foundation, Washington, DC, USA, 2003.
  17. C. Kok and P. N. Sambrook, “Secondary osteoporosis in patients with an osteoporotic fracture,” Best Practice and Research, vol. 23, no. 6, pp. 769–779, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Khosla, “Minireview: the OPG/RANKL/RANK system,” Endocrinology, vol. 142, no. 12, pp. 5050–5055, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. K. T. Steeve, P. Marc, T. Sandrine, H. Dominique, and F. Yannick, “IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology,” Cytokine and Growth Factor Reviews, vol. 15, no. 1, pp. 49–60, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Rossa, K. Ehmann, M. Liu, C. Patil, and K. L. Kirkwood, “MKK3/6-p38 MAPK signaling is required for IL-1β and TNF-α-induced RANKL expression in bone marrow stromal cells,” Journal of Interferon and Cytokine Research, vol. 26, no. 10, pp. 719–729, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Kanematsu, T. Sato, H. Takai, K. Watanabe, K. Ikeda, and Y. Yamada, “Prostaglandin E2 induces expression of receptor activator of nuclear factor-κB ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency,” Journal of Bone and Mineral Research, vol. 15, no. 7, pp. 1321–1329, 2000. View at Google Scholar · View at Scopus
  22. K. Suda, N. Udagawa, N. Sato et al., “Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation,” Journal of Immunology, vol. 172, no. 4, pp. 2504–2510, 2004. View at Google Scholar · View at Scopus
  23. M. J. Steinbeck, J.-K. Kim, M. J. Trudeau, P. V. Hauschka, and M. J. Karnovsky, “Involvement of hydrogen peroxide in the differentiation of clonal HD- 11EM cells into osteoclast-like cells,” Journal of Cellular Physiology, vol. 176, no. 3, pp. 574–587, 1998. View at Publisher · View at Google Scholar
  24. J. Lean, B. Kirstein, Z. Urry, T. Chambers, and K. Fuller, “Thioredoxin-1 mediates osteoclast stimulation by reactive oxygen species,” Biochemical and Biophysical Research Communications, vol. 321, no. 4, pp. 845–850, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Ha, H. Bok Kwak, S. Woong Lee et al., “Reactive oxygen species mediate RANK signaling in osteoclasts,” Experimental Cell Research, vol. 301, no. 2, pp. 119–127, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. N. K. Lee, Y. G. Choi, J. Y. Baik et al., “A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation,” Blood, vol. 106, no. 3, pp. 852–859, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Khosla, D. Burr, J. Cauley et al., “Bisphosphonate-associated osteonecrosis of the jaw: report of a Task Force of the American Society for Bone and Mineral Research,” Journal of Bone and Mineral Research, vol. 22, no. 10, pp. 1479–1491, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. J. J. Stepan, F. Alenfeld, G. Boivin, J. H. M. Feyen, and P. Lakatos, “Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis,” Endocrine Regulations, vol. 37, no. 4, pp. 225–238, 2003. View at Google Scholar · View at Scopus
  29. I. Writing Group for the Women's Health Initiative, “Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial,” Journal of the American Medical Association, vol. 288, no. 3, pp. 321–333, 2002. View at Google Scholar · View at Scopus
  30. E. Canalis, A. Giustina, and J. P. Bilezikian, “Mechanisms of anabolic therapies for osteoporosis,” New England Journal of Medicine, vol. 357, no. 9, pp. 850–916, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. B. B. Aggarwal, C. Sundaram, S. Prasad, and R. Kannappan, “Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases,” Biochemical Pharmacology, vol. 80, no. 11, pp. 1613–1631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Norazlina, S. Ima-Nirwana, M. T. A. Gapor, and B. A. Kadir Khalid, “Tocotrienols are needed for normal bone calcification in growing female rats,” Asia Pacific Journal of Clinical Nutrition, vol. 11, no. 3, pp. 194–199, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Norazlina, C. W. Chua, and S. Ima-Nirwana, “Vitamin E deficiency reduced lumbar bone calcium content in female rats,” Medical Journal of Malaysia, vol. 59, no. 5, pp. 623–630, 2004. View at Google Scholar · View at Scopus
  34. M. Z. Mehat, A. N. Shuid, N. Mohamed, N. Muhammad, and I. N. Soelaiman, “Beneficial effects of vitamin e isomer supplementation on static and dynamic bone histomorphometry parameters in normal male rats,” Journal of Bone and Mineral Metabolism, vol. 28, no. 5, pp. 503–509, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. A. N. Shuid, Z. Mehat, N. Mohamed, N. Muhammad, and I. N. Soelaiman, “Vitamin E exhibits bone anabolic actions in normal male rats,” Journal of Bone and Mineral Metabolism, vol. 28, no. 2, pp. 149–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. B. H. Arjmandi, S. Juma, A. Beharka, M. S. Bapna, M. Akhter, and S. N. Meydani, “Vitamin E improves bone quality in the aged but not in young adult male mice,” Journal of Nutritional Biochemistry, vol. 13, no. 9, pp. 543–549, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Maniam, N. Mohamed, A. N. Shuid, and I. N. Soelaiman, “Palm tocotrienol exerted better antioxidant activities in bone than α-tocopherol,” Basic and Clinical Pharmacology and Toxicology, vol. 103, no. 1, pp. 55–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Hermizi, O. Faizah, S. Ima-Nirwana, S. Ahmad Nazrun, and M. Norazlina, “Beneficial effects of tocotrienol and tocopherol on bone histomorphometric parameters in Sprague-Dawley male rats after nicotine cessation,” Calcified Tissue International, vol. 84, no. 1, pp. 65–74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Norazlina, H. Hermizi, O. Faizah, A. S. Nazrun, M. Norliza, and S. Ima-Nirwana, “Vitamin E reversed nicotine-induced toxic effects on bone biochemical markers in male rats,” Archives of Medical Science, vol. 6, no. 4, pp. 505–512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. N. S. Ahmad, B. A. K. Khalid, D. A. Luke, and S. I. Nirwana, “Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone,” Clinical and Experimental Pharmacology and Physiology, vol. 32, no. 9, pp. 761–770, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Ima-Nirwana and S. Suhaniza, “Effects of tocopherols and tocotrienols on body composition and bone calcium content in adrenalectomized rats replaced with dexamethasone,” Journal of Medicinal Food, vol. 7, no. 1, pp. 45–51, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Ima-Nirwana and H. Fakhrurazi, “Palm vitamin E protects bone against dexamethasone-induced osteoporosis in male rats,” Medical Journal of Malaysia, vol. 57, no. 2, pp. 133–141, 2002. View at Google Scholar
  43. B. J. Smith, E. A. Lucas, R. T. Turner et al., “Vitamin E provides protection for bone in mature hindlimb unloaded male rats,” Calcified Tissue International, vol. 76, no. 4, pp. 272–279, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Ima-Nirwana, A. Kiftiah, A. G. Zainal, M. Norazlina, M. T. Gapor, and B. A. K. Khalid, “Palm vitamin E prevents osteoporosis in orchidectomized growing male rats,” Natural Product Sciences, vol. 6, no. 4, pp. 155–160, 2000. View at Google Scholar · View at Scopus
  45. A. T. Aktifanus, A. N. Shuid, N. H. A. Rashid et al., “Comparison of the effects of tocotrienol and estrogen on the bone markers and dynamic changes in postmenopausal osteoporosis rat model,” Asian Journal of Animal and Veterinary Advances, vol. 7, no. 3, pp. 225–234, 2012. View at Publisher · View at Google Scholar
  46. M. Norazlina, S. Ima-Nirwana, M. T. Gapor, and B. A. K. Khalid, “Palm vitamin E is comparable to α-tocopherol in maintaining bone mineral density in ovariectomised female rats,” Experimental and Clinical Endocrinology and Diabetes, vol. 108, no. 4, pp. 305–310, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Nazrun, A. Khairunnur, M. Norliza, M. Norazlina, and S. Ima Nirwana, “Effects of palm tocotrienol on oxidative stress and bone strength in ovariectomised rats,” Medicine and Health, vol. 3, no. 2, pp. 83–90, 2008. View at Google Scholar
  48. J-.H. Lee, H. N. Kim, D. Yang et al., “Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling,” Journal of Biological Chemistry, vol. 284, no. 20, pp. 13725–13734, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Ha, J.-H. Lee, H.-N. Kim, and Z. H. Lee, “α-Tocotrienol inhibits osteoclastic bone resorption by suppressing RANKL expression and signaling and bone resorbing activity,” Biochemical and Biophysical Research Communications, vol. 406, no. 4, pp. 546–551, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Fujita, M. Iwasaki, H. Ochi et al., “Vitamin E decreases bone mass by stimulating osteoclast fusion,” Nature Medicine, vol. 18, no. 4, pp. 589–594, 2012. View at Publisher · View at Google Scholar
  51. I. M. C. M. Rietjens, M. G. Boersma, L. D. Haan et al., “The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids,” Environmental Toxicology and Pharmacology, vol. 11, no. 3-4, pp. 321–333, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. A. M. Nizar, A. S. Nazrun, M. Norazlina, M. Norliza, and S. Ima Nirwana, “Low dose of tocotrienols protects osteoblasts against oxidative stress,” La Clinica Terapeutica, vol. 162, no. 6, pp. 533–538, 2011. View at Google Scholar
  53. S.-P. Lee, G. Y. Mar, and L. T. Ng, “Effects of tocotrienol-rich fraction on exercise endurance capacity and oxidative stress in forced swimming rats,” European Journal of Applied Physiology, vol. 107, no. 5, pp. 587–595, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Norazlina, J. Maizatul-Neza, A. Azarina, A. S. Nazrun, M. Norliza, and S. Ima-Nirwana, “Effects of vitamin E on receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in rats treated with nicotine,” Medical Journal of Malaysia, vol. 65, no. 1, pp. 14–17, 2010. View at Google Scholar · View at Scopus
  55. R. Comitato, K. Nesaretnam, G. Leoni et al., “A novel mechanism of natural vitamin E tocotrienol activity: involvement of ERβ signal transduction,” American Journal of Physiology-Endocrinology and Metabolism, vol. 297, no. 2, pp. E427–E437, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Nazrun, M. Norazlina, M. Norliza, and S. Ima Nirwana, “The anti-inflammatory role of vitamin E in prevention of osteoporosis,” Advances in Pharmacological Sciences, vol. 2012, Article ID 142702, 2012. View at Google Scholar
  57. C.-S. You, T. J. Sontag, J. E. Swanson, and R. S. Parker, “Long-chain carboxychromanols are the major metabolites of tocopherols and tocotrienols in A549 lung epithelial cells but not HepG2 cells,” Journal of Nutrition, vol. 135, no. 2, pp. 227–232, 2005. View at Google Scholar · View at Scopus
  58. C. R. Meier, R. G. Schlienger, M. E. Kraenzlin, B. Schlegel, and H. Jick, “HMG-CoA reductase inhibitors and the risk of fractures,” Journal of the American Medical Association, vol. 283, no. 24, pp. 3205–3210, 2000. View at Google Scholar · View at Scopus
  59. P. S. Wang, D. H. Solomon, H. Mogun, and J. Avorn, “HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients,” Journal of the American Medical Association, vol. 283, no. 24, pp. 3211–3216, 2000. View at Google Scholar · View at Scopus
  60. M. W. C. J. Schoofs, M. C. J. M. Sturkenboom, M. Van Der Klift, A. Hofman, H. A. P. Pols, and B. H. C. Stricker, “HMG-CoA reductase inhibitors and the risk of vertebral fracture,” Journal of Bone and Mineral Research, vol. 19, no. 9, pp. 1525–1530, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. G. Mundy, R. Garrett, S. Harris et al., “Stimulation of bone formation in vitro and in rodents by statins,” Science, vol. 286, no. 5446, pp. 1946–1949, 1999. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Sugiyama, T. Kodama, K. Konishi, K. Abe, S. Asami, and S. Oikawa, “Compactin and simvastatin, but not pravastatin, induce sone morphogenetic protein-2 in human osteosarcoma cells,” Biochemical and Biophysical Research Communications, vol. 271, no. 3, pp. 688–692, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. R. A. Parker, B. C. Pearce, R. W. Clark, D. A. Gordon, and J. J. K. Wright, “Tocotrienols regulate cholesterol production in mammalian cells by post- transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase,” Journal of Biological Chemistry, vol. 268, no. 15, pp. 11230–11238, 1993. View at Google Scholar · View at Scopus
  64. H. T. Khor, D. Y. Chieng, and K. K. Ong, “Tocotrienols inhibit liver HMG CoA reductase activity in the guinea pig,” Nutrition Research, vol. 15, no. 4, pp. 537–544, 1995. View at Publisher · View at Google Scholar · View at Scopus
  65. T. T. Ng and H. T. Khor, “Effects of administration of α-tocopherol and tocotrienols on serum lipids and liver HMG CoA reductase activity,” International Journal of Food Sciences and Nutrition, vol. 51, pp. S3–S11, 2000. View at Google Scholar · View at Scopus